Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ARCT stock hub

Arcturus Therapeutics Holdings Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ARCTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

262.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ARCT

In the news

Latest news · ARCT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-37

P25 -105.6P50 -46.5P75 -3.1

ROIC-2,283

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ARCT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001566049
Company name	Arcturus Therapeutics Holdings Inc.
Country	United States
Country code	US
Cusip	03969T109
Employees	111
Employees Change	-65%
Employees Change Percent	-36.93
Enterprise value	$70.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US03969T1097
Last refreshed	2026-05-10
Market cap	$262.1M
Market cap category	Micro-Cap
Price	$9.22
Price currency	USD
Rev Per Employee	492,882.88x
Sector	Healthcare
Sic	2834
Symbol	ARCT
Website	https://arcturusrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.02%
EV Sales Forward	1.89x
EV/Sales	1.29x
FCF yield	-22.39%
P/B ratio	1.37x
P/S ratio	4.79x
PS Forward	7.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-161.52%
EBITDA Margin	-156.25%
Gross margin	-105.1%
Gross Profit	$-57.5M
Net Income	$-78.7M
Net Income Growth Years	1%
Pretax Margin	-143.8%
Profit Margin	-143.8%
Profit Per Employee	$-708,748
ROA	-19.14
Roa5y	-13.89
ROCE	-41.87
ROE	-37.01
Roe5y	-26.47
ROIC	-2,283

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-15.81%
Cagr3y	-30.18%
Cagr5y	-21.94%
EPS Growth Years	1
Revenue Growth	-61.92x
Revenue Growth Q	-92.99x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.04x
Revenue Growth5 Y	43.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.19
Assets	$245.4M
Cash	$211.4M
Current Assets	$216.9M
Current Liabilities	$34.4M
Debt	$19.7M
Debt Equity	$0.1
Equity	$191.4M
Interest Coverage	-9,818.3
Liabilities	$54M
Long Term Assets	$28.5M
Long Term Liabilities	$19.7M
Net Cash	$191.7M
Net Cash By Market Cap	$73.15
Net Cash Growth	9.99%
Net Debt Equity	$-1
Tangible Book Value	$191.4M
Tangible Book Value Per Share	$6.73
WACC	16.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.31
Net Working Capital	$-28.9M
Quick ratio	6.19
Working Capital	$182.5M
Working Capital Turnover	$0.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.43%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-15.8%
200-day SMA	10.88
3Y total return	-65.98%
50-day SMA	7.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.01%
All Time High	129.7
All Time High Change	-92.89%
All Time High Date	2020-12-07
All Time Low	4.11
All Time Low Change	124.33%
All Time Low Date	2018-12-28
ATR	0.58
Beta	2.42
Beta1y	2.19
Beta2y	2.25
Ch YTD	50.41
High	9.58
High52	24.17
High52 Date	2025-10-21
High52ch	-61.85%
Low	7.86
Low52	5.85
Low52 Date	2025-11-20
Low52ch	57.61%
Ma50ch	16.38%
Premarket Change Percent	-7.75
Premarket Price	$8.21
Premarket Volume	16,102
Price vs 200-day SMA	-15.23%
RSI	62.06
RSI Monthly	42.06
RSI Weekly	51.56
Sharpe ratio	0.3x
Sortino ratio	0.47
Total Return	-2.43%
Tr YTD	50.41
Tr1m	8.34%
Tr1w	6.84%
Tr3m	21.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$21.75
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-1.04
Earnings Revenue Estimate	7,067,744x
Earnings Revenue Estimate Growth	-75.95x
Operating Income	$-88.4M
Operating margin	-161.5
Price target	$24.11
Price Target Change	$161
Price Target Change Top	$136

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,153,166%
Float Percent	92.01%
Net Borrowing	-15,000,000
Shares Insiders	7.99%
Shares Institutions	80.45%
Shares Out	28,423,069
Shares Qo Q	1.1%
Shares Yo Y	2.43%
Short Float	23.91%
Short Ratio	11.9
Short Shares	22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-81.7M
Average Volume	366,543.35x
Bv Per Share	6.73
CAPEX	$-93,000
Ch1m	8.34
Ch1w	6.84
Ch1y	-15.8
Ch3m	21.8
Ch3y	-65.98
Ch5y	-71.01
Ch6m	5.73
Change	3.6%
Change From Open	12.17
Close	8.9
Days Gap	-7.64
Depreciation Amortization	2,882,000
Dollar Volume	8,609,571.5
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-88.4M
EBITDA	$-85.5M
EPS	$-2.84
F Score	2
FCF	$-58.7M
FCF EV Yield	-83.37x
FCF Per Share	$-2.06
Financing CF	-1,797,000
Fiscal Year End	December
Founded	2,013
Investing CF	-59,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2019-03-18
Ma150	8.84
Ma150ch	4.33%
Ma20	8.7
Ma20ch	6.04%
Net CF	-60,430,000
Next Earnings Date	2026-08-10
Open	8.22
Optionable	Yes
Position In Range	79.07
Post Close	9.22
Postmarket Change Percent	-0.76
Postmarket Price	$9.15
Ppne	26,501,000
Pre Close	8.9
Price Date	2026-05-08
Ptbv Ratio	1.37
Relative Volume	2.55x
Revenue	54,710,000x
SBC By Revenue	42.17x
Share Based Comp	23,071,000
Tr6m	5.73%
Us State	California
Volume	933,793

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ARCT pay a dividend?

Capital-return profile for this ticker.

Performance

ARCT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ARCT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.4%

Float: +92.0% of shares outstanding

Insider ownership

+8.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ARCT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.1

Neutral momentum band

Price vs 200-day MA

-15.2%

50/200-day relationship not available

Beta (5Y)

2.42

More volatile than the market

Sharpe ratio

0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ARCT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ARCT stock rating?

Arcturus Therapeutics Holdings Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ARCT analysis?

The full report lives at /stocks/ARCT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ARCT?

The latest report frames ARCT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ARCT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.